Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Quantitative classification of harbor seal breeding calls in Georgia Strait, Canada.

Nikolich K, Frouin-Mouy H, Acevedo-Gutiérrez A.

J Acoust Soc Am. 2016 Aug;140(2):1300. doi: 10.1121/1.4961008.

PMID:
27586756
2.

A pharmacological screening approach for discovery of neuroprotective compounds in ischemic stroke.

Beraki S, Litrus L, Soriano L, Monbureau M, To LK, Braithwaite SP, Nikolich K, Urfer R, Oksenberg D, Shamloo M.

PLoS One. 2013 Jul 18;8(7):e69233. doi: 10.1371/journal.pone.0069233. Print 2013.

3.

The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke.

Ruscher K, Shamloo M, Rickhag M, Ladunga I, Soriano L, Gisselsson L, Toresson H, Ruslim-Litrus L, Oksenberg D, Urfer R, Johansson BB, Nikolich K, Wieloch T.

Brain. 2011 Mar;134(Pt 3):732-46. doi: 10.1093/brain/awq367. Epub 2011 Jan 28.

PMID:
21278085
4.

KIBRA: A New Gateway to Learning and Memory?

Schneider A, Huentelman MJ, Kremerskothen J, Duning K, Spoelgen R, Nikolich K.

Front Aging Neurosci. 2010 Feb 12;2:4. doi: 10.3389/neuro.24.004.2010. eCollection 2010.

5.

Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials.

Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M; STAIR VI Consortium..

Stroke. 2009 Jul;40(7):2594-600. doi: 10.1161/STROKEAHA.109.552554. Epub 2009 May 28.

6.

Update of the stroke therapy academic industry roundtable preclinical recommendations.

Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH; STAIR Group..

Stroke. 2009 Jun;40(6):2244-50. doi: 10.1161/STROKEAHA.108.541128. Epub 2009 Feb 26. Review.

7.

Expression and function of striatal enriched protein tyrosine phosphatase is profoundly altered in cerebral ischemia.

Braithwaite SP, Xu J, Leung J, Urfer R, Nikolich K, Oksenberg D, Lombroso PJ, Shamloo M.

Eur J Neurosci. 2008 May;27(9):2444-52. doi: 10.1111/j.1460-9568.2008.06209.x.

8.

Npas4, a novel helix-loop-helix PAS domain protein, is regulated in response to cerebral ischemia.

Shamloo M, Soriano L, von Schack D, Rickhag M, Chin DJ, Gonzalez-Zulueta M, Gido G, Urfer R, Wieloch T, Nikolich K.

Eur J Neurosci. 2006 Nov;24(10):2705-20.

PMID:
17156197
9.

Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP).

Braithwaite SP, Adkisson M, Leung J, Nava A, Masterson B, Urfer R, Oksenberg D, Nikolich K.

Eur J Neurosci. 2006 Jun;23(11):2847-56.

PMID:
16819973
10.

Mechanisms of neural plasticity following brain injury.

Wieloch T, Nikolich K.

Curr Opin Neurobiol. 2006 Jun;16(3):258-64. Epub 2006 May 18. Review.

PMID:
16713245
11.

Targeting of the receptor protein tyrosine phosphatase beta with a monoclonal antibody delays tumor growth in a glioblastoma model.

Foehr ED, Lorente G, Kuo J, Ram R, Nikolich K, Urfer R.

Cancer Res. 2006 Feb 15;66(4):2271-8.

12.

Comprehensive regional and temporal gene expression profiling of the rat brain during the first 24 h after experimental stroke identifies dynamic ischemia-induced gene expression patterns, and reveals a biphasic activation of genes in surviving tissue.

Rickhag M, Wieloch T, Gidö G, Elmér E, Krogh M, Murray J, Lohr S, Bitter H, Chin DJ, von Schack D, Shamloo M, Nikolich K.

J Neurochem. 2006 Jan;96(1):14-29. Epub 2005 Nov 21.

13.

Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2.

Ram R, Lorente G, Nikolich K, Urfer R, Foehr E, Nagavarapu U.

J Neurooncol. 2006 Feb;76(3):239-48.

PMID:
16234985
14.

Death-associated protein kinase is activated by dephosphorylation in response to cerebral ischemia.

Shamloo M, Soriano L, Wieloch T, Nikolich K, Urfer R, Oksenberg D.

J Biol Chem. 2005 Dec 23;280(51):42290-9. Epub 2005 Oct 3.

15.

FAS associated phosphatase (FAP-1) blocks apoptosis of astrocytomas through dephosphorylation of FAS.

Foehr ED, Lorente G, Vincent V, Nikolich K, Urfer R.

J Neurooncol. 2005 Sep;74(3):241-8.

PMID:
16187021
16.

Functional comparison of long and short splice forms of RPTPbeta: implications for glioblastoma treatment.

Lorente G, Nelson A, Mueller S, Kuo J, Urfer R, Nikolich K, Foehr ED.

Neuro Oncol. 2005 Apr;7(2):154-63.

17.

GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion.

Shashidhar S, Lorente G, Nagavarapu U, Nelson A, Kuo J, Cummins J, Nikolich K, Urfer R, Foehr ED.

Oncogene. 2005 Mar 3;24(10):1673-82.

PMID:
15674329
18.

Receptor protein tyrosine phosphatase zeta as a therapeutic target for glioblastoma therapy.

Müller S, Lamszus K, Nikolich K, Westphal M.

Expert Opin Ther Targets. 2004 Jun;8(3):211-20. Review.

PMID:
15161428
19.

Identification of cathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using a functional genomics approach.

Gan L, Ye S, Chu A, Anton K, Yi S, Vincent VA, von Schack D, Chin D, Murray J, Lohr S, Patthy L, Gonzalez-Zulueta M, Nikolich K, Urfer R.

J Biol Chem. 2004 Feb 13;279(7):5565-72. Epub 2003 Nov 10. Erratum in: J Biol Chem. 2004 May 28;279(22):23845.

20.

Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma.

Mattiasson G, Shamloo M, Gido G, Mathi K, Tomasevic G, Yi S, Warden CH, Castilho RF, Melcher T, Gonzalez-Zulueta M, Nikolich K, Wieloch T.

Nat Med. 2003 Aug;9(8):1062-8. Epub 2003 Jul 13.

PMID:
12858170

Supplemental Content

Loading ...
Support Center